Diabetes Insipidus Nephrogenic
Mostrando 1-12 de 36 artigos, teses e dissertações.
-
1. Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus
“What's in a name? That which we call a rose / By any other name would smell as sweet” (Juliet, from Romeo and Juliet by William Shakespeare). Shakespeare's implication is that a name is nothing but a word and it therefore represents a convention with no intrinsic meaning. Whilst this may be relevant to romantic literature, disease names do have real mea
Archives of Endocrinology and Metabolism. Publicado em: 2022
-
2. Primary large cell prostate neuroendocrine carcinoma with central and nephrogenic diabetes insipidus
Resumo Os níveis de sintomatologia depressiva, estresse e ansiedade têm crescido em todo o mundo comprometendo a qualidade de vida e bem estar das pessoas das mais diferentes idades. Assim, o presente estudo teve como objetivo avaliar os níveis desses sintomas em 410 estudantes (233 ingressantes e 177 concluintes) dos cursos de saúde de uma universidade
Int. braz j urol.. Publicado em: 2020-10
-
3. Autoimmune central diabetes insipidus in a patient with ureaplasma urealyticum infection and review on new triggers of immune response
Diabetes insipidus is a disease in which large volumes of dilute urine (polyuria) are excreted due to vasopressin (AVP) deficiency [central diabetes insipidus (CDI)] or to AVP resistance (nephrogenic diabetes insipidus). In the majority of patients, the occurrence of CDI is related to the destruction or degeneration of neurons of the hypothalamic supraoptic
Arch. Endocrinol. Metab.. Publicado em: 28/08/2015
-
4. Vias intracelulares da ação do Sildenafil no diabetes insipidus induzido pelo lítio / Sildenafil action in lithium-induced NDI: intracellular pathway
Patients taking lithium to treat bipolar disorder often present polyuria and urinary concentrating defect. In addition, lithium-treated animals present lower cyclic adenosine monophosphate production in response to vasopressin. Sildenafil (Sil), a phosphodiesterase 5 (PDE5) inhibitor, elevates intracellular cyclic guanosine monophosphate (cGMP) levels, leadi
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 13/06/2012
-
5. Novel compound aquaporin 2 mutations in nephrogenic diabetes insipidus
Clinics. Publicado em: 2012
-
6. Efeito da carbamazepina na reabsorção de água pelo ducto coletor medular interno de ratos normais e de ratos com diabetes insípido nefrogênico induzido pelo lítio / Effect of carbamazepine on water absorption in the inner medullary collecting duct from normal rats and from rats with lithium-induced diabetes insipidus
Carbamazepine (Carba) is an anticonvulsant and a psychotropic medication commonly used in the treatment of patients with intellectual disability (ID). This drug has been used to try to decrease the urinary volume in Diabetes Insipidus (DI) because Carba presents an antidiuretic effect, but the incidence of the hyponatremia in neurological patients is a commo
Publicado em: 2010
-
7. Nephrogenic diabetes insipidus (NDI): clinical, laboratory and genetic characterization of five Brazilian patients
INTRODUCTION: Nephrogenic diabetes insipidus is characterized by a lack of response in the distal nephron to the antidiuretic hormone arginine vasopressin. Manifestations include polyuria, polydipsia, hyposthenuria, recurrent episodes of dehydration and fever and growth failure. Most cases are caused by mutations in the AVPR2 gene. The mutant receptors are t
Clinics. Publicado em: 2009-05
-
8. Estudo da ação do inibidor de fosfodiesterase (sildenafil) no diabetes insipidus induzido pelo lítio / Role of phosphodiesterase inhibitor(sildenafil) in lithium-induced diabetes insipidus
Patients taking lithium to treat bipolar disorder often present polyuria and urinary concentrating defect. In addition, lithium-treated animals present lower cyclic adenosine monophosphate production in response to vasopressin. Sildenafil (Sil), a phosphodiesterase 5 (PDE5) inhibitor, elevates intracellular cyclic guanosine monophosphate (cGMP) levels, leadi
Publicado em: 2008
-
9. Nephrogenic diabetes insipidus and Werdnig-Hoffmann disease in a child: an unusual association.
The unusual association of Werdnig-Hoffmann disease and nephrogenic diabetes insipidus in a 5-month-old child is described for the first time. The association is casual, considering the different pathways of genetical transmission in these two diseases. The possibility of identifying the heterozygote is discussed and it appears to be limited to nephrogenic d
-
10. Aldose Reductase-Deficient Mice Develop Nephrogenic Diabetes Insipidus
Aldose reductase (ALR2) is thought to be involved in the pathogenesis of various diseases associated with diabetes mellitus, such as cataract, retinopathy, neuropathy, and nephropathy. However, its physiological functions are not well understood. We developed mice deficient in this enzyme and found that they had no apparent developmental or reproductive abno
American Society for Microbiology.
-
11. Cellular Action of Vasopressin in Medullary Tubules of Mice with Hereditary Nephrogenic Diabetes Insipidus
Our previous studies (1974. J. Clin. Invest.54: 753-762.) suggested that impaired metabolism of cyclic AMP (cAMP) may be involved in the renal unresponsiveness to vasopressin (VP) in mice with hereditary nephrogenic diabetes insipidus (NDI). To localize such a defect to specific segments of the nephron, we studied the activities of VP-sensitive adenylate cyc
-
12. Autosomal dominant hypoparathyroidism: a proband with concurrent nephrogenic diabetes insipidus.
In this paper we report an extended family with well documented autosomal dominant hypoparathyroidism which was ascertained through a proband with coincident nephrogenic diabetes insipidus. Clinical findings were limited to a slight decrease in overall stature and to clinical signs of hypocalcaemia. Intelligence was normal and two patients were asymptomatic.